Indonesia is the fourth most populous country on Earth, home to more than 270 million people spread across more than 17,000 islands. Its healthcare system has made remarkable gains in the past two decades. But for women facing breast cancer — particularly those outside Java — the picture remains deeply troubling.
The numbers
According to the World Health Organization, Indonesia registered approximately 68,000 new breast cancer cases in 2022, making it the most common cancer among Indonesian women. The five-year survival rate is estimated at around 40% — compared to 87% in the United Kingdom and over 90% in the United States. Late diagnosis is the primary reason for that gap.
- Over 60% of Indonesian women are diagnosed at Stage III or IV, when cancer has already spread beyond the breast.
- Fewer than 5% of Indonesian women report ever having had a clinical breast examination.
- Indonesia has approximately 0.2 mammography machines per 100,000 people — compared to around 30 in the UK.
- The vast majority of those machines are located in Jakarta and other major cities.
Why diagnosis happens so late
Indonesian women face a cascade of barriers between first noticing a symptom and receiving a diagnosis. Many live in rural or island communities hours from the nearest hospital. Even where facilities exist, costs are prohibitive for those not covered by the national insurance scheme. And even where cost is not the issue, awareness often is.
Health literacy about breast cancer varies enormously across Indonesia's regions and population groups. Many women — and crucially, many of the community and religious figures who shape their decisions — hold misconceptions about the disease: that a painless lump cannot be cancer, that it is caused by a blow or bruise, that traditional remedies are an alternative to medical treatment. These beliefs are not irrational given the information environments in which many women live. They are, however, deadly.
What the government is doing — and where the gaps remain
Indonesia's Ministry of Health has committed in principle to early detection of breast cancer as a public health priority, and the national health insurance programme (JKN) does cover some screening and treatment costs. But implementation has been uneven. In practice, the availability of screening outside major cities remains extremely limited, and community-level awareness programmes are inconsistent.
This is where NGO-led programmes — including those funded by Breast Cancer Awareness — are filling a critical gap. Our partners in Indonesia run mobile screening units that travel to rural and peri-urban communities, train community health workers and religious leaders as breast cancer awareness advocates, and work alongside local health authorities to improve the referral pathway between screening and treatment.
Progress is possible
The picture is not hopeless. Where sustained intervention has been applied — as in parts of East Java and Yogyakarta — early detection rates have improved significantly within a few years. The challenge is scale: reaching the breadth of Indonesia's geography and the diversity of its communities requires resources and sustained commitment that only consistent donor support can provide.
68,000 new cases a year. Each one is a woman with a family, a community, a future that depends on whether she is found in time. Breast Cancer Awareness is working to ensure more of them are.